Yubo International Biotech annual return on equity
2021
Yubo International Biotech Return on Equity (ROE) Growth & History (YBGJ)
Yubo International Biotech's return on equity was −297.65% for fiscal 2021.
View full Yubo International Biotech company overviewYubo International Biotech annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −297.65% | — |
Yubo International Biotech quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2021 | 2021-12-31 | −871.89% | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −85.00% | — |
| Q2 2021 · Jun 30 | 2021-06-30 | −49.46% | — |
| Q1 2021 · Mar 31 | 2021-03-31 | −41.90% | — |
Yubo International Biotech return on equity trends
The latest reported quarter, Q4 2021, shows −871.89%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗